32.jpg)
56.jpg)
SOL-GEL NANOSTRUCTURED TITANIA RESERVOIRS FOR USE IN THE CONTROLLED RELEASE OF DRUGS IN THE CENTRAL NERVOUS SYSTEM AND METHOD OF SYNTHESIS
Patent number:
EP2020987
No items found.
The invention is related to a sol-gel nanostructured titania reservoir and its synthesis which is biocompatible with brain tissue. The pore size distribution, crystallite size and the extent of the crystalline phase distribution of anatase, brookite and rutile can be fully controlled. This device may be used to contain neurological drugs. It may be inserted directly into brain tissue for the purpose of the controlled time release of drugs over a period of from 6 months to three years.
Countries:
Mexico
Regions:
No items found.
Centers:
UNIVERSIDAD AUTONOMA METROPOLITANA
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 8 – system complete and qualified
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
SDG03: Good health and well-being
Applications
Se trata de un depósito que durante la síntesis se manipula el tamaño de poro, que es biocompatible incluso con el tejido cerebral y sirve para la liberación controlada de fármacos
Comments
Other related patents
Health
METHOD FOR PROGNOSIS OF THE OUTCOME OF PATIENTS WITH HEART FAILURE (HF)
Health
Chemicals
Food & Agro
BINARY COMPLEX OF AN ORGANIC ZINC CHELATE AND FLAVONOIDS AND COMPOSITION COMPRISING IT FOR STIMULATING THE IMMUNE SYSTEM AND ENHANCING RESISTANCE TO VIRAL OR BACTERIAL INFECTIOUS DISEASES
Health